Skip to content

Compliance to ERAS After Gastric Surgery

Phase II Study Evaluating the Compliance to the Enhanced Recovery After Surgery (ERAS) Program in Patients Undergoing Gastrectomy for Gastric Carcinoma

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01653496
Acronym
ERAS
Enrollment
168
Registered
2012-07-31
Start date
2012-07-31
Completion date
2014-02-28
Last updated
2016-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomach Neoplasms

Keywords

Gastric cancer, Perioperative care, Enhanced recovery after surgery, Multimodal rehabilitation, Fast track surgery, Gastrectomy

Brief summary

The purpose of this study is to prospectively evaluate the overall compliance to the enhanced recovery after surgery (ERAS) program in patients undergoing gastric cancer surgery.

Detailed description

The feasibility and effectiveness of ERAS program for various major surgical procedures have been well studies in the literature. However, ERAS program has not been widely accepted for patients undergoing gastric cancer surgery because of the paucity of evidence about its feasibility and efficacy. In this study, we developed ERAS program for gastric cancer surgery, based on the systemic review about perioperative cares. The main elements of ERAS program includes: 1preoperative patient education, 2)no preoperative bowel preparation, 3) provision of normal diet until the night before surgery, 4)carbohydrate rich drink 2 hrs before surgery, 5)epidural anesthesia for pain control, 6) local wound anesthetic infiltration for pain control, 7)no routine abdominal drain, 8)no naso-gastric tube insertion, 9)intraoperative antibiotics, 10)thromboprophylaxis using intermittent pneumatic compression device, 11)intraoperative normothermia using warm air blanket, 12)low oxygen supply during immediate postoperative period, 13)restrictive postoperative fluid administration, 14)early postoperative oral diet, 15)early active ambulation, 16)early removal of the urinary catheter, 17)patient education before discharge, and 18)hospital discharge based on discharge criteria. The aim of study is to evaluate the compliance to these main elements of ERAS program in patients undergoing gastric cancer surgery. Previously reported data about ERAS program for colon surgery reported overall compliance as about 65%. Considering that this is a single center study, we expected overall compliance rate of 70%. Therefore, the sample size of 173 patients was calculated based on this expected compliance rate, with permitted error of 95% confidence interval of 14%.

Interventions

PROCEDUREEnhanced recovery after surgery

The main 18 elements of ERAS program included are described in detail in the brief summary of the study

Sponsors

Chonnam National University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients who are to undergo gastric cancer surgery * ASA score \< 3 * ECOG performance status 0-1 * Adequate hepatic, renal, and hematologic function * Written informed consent

Exclusion criteria

* Previous abdominal operation history * Concommitant other organ malignant disease * Preoperative chemotherapy or radiation therapy * Concommitant other organ resection during surgery * Emergency operation due to bleeding or perforation * Active underlying medical illness * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Overall compliance to the ERAS program90 daysPatient's compliance to the 18 main elements of ERAS program

Secondary

MeasureTime frameDescription
Morbidity90 daysPostoperative complications means any complications occured within 90 days after operation, and will be assessed based on the predefined definition and severity of postoperative complication of our institution.
Hospital stay90 daysThe length of hospital stay means the duration from the operation until hospital discharge.
Mortality90 daysAny death related to surgery within 90 days after surgery

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026